array(3) { ["company_details"]=> array(13) { ["name"]=> string(9) "Msci Inc." ["slug"]=> string(17) "8b2a4-us-msci-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/f2f7bd00-6d76-42a8-b5ad-fda1e32e6434" ["description"]=> string(489) "MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process." ["address_street"]=> string(22) "250 Greenwich St FL 49" ["address_place"]=> string(8) "New York" ["address_region"]=> string(8) "New York" ["founding_date"]=> string(10) "1969-02-28" ["website_domain"]=> string(8) "msci.com" ["website_url"]=> string(20) "https://www.msci.com" ["industry_codes"]=> array(4) { [0]=> string(17) "Investment Advice" [1]=> string(29) "Computer Programming Services" [2]=> string(43) "Business Services, Not Elsewhere Classified" [3]=> string(30) "Management Consulting Services" } ["employee_count"]=> int(4303) ["article_count"]=> int(73) } ["articles"]=> array(2) { [0]=> array(7) { ["title_en"]=> string(61) "Royalty Pharma Appoints Henry Fernandez and Ted Love to Board" ["snippet_en"]=> string(242) "Royalty Pharma Appoints Henry Fernandez and Ted Love to Board 8/9/20 NEW YORK (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX) today announced the appointments of Henry A. Fernandez and Ted W. Love, M.D. to the company 's Board of Directors," ["url"]=> string(108) "https://newyork.citybizlist.com/article/623004/royalty-pharma-appoints-henry-fernandez-and-ted-love-to-board" ["image_url"]=> NULL ["source"]=> string(15) "citybizlist.com" ["publication_date"]=> string(10) "2020-08-09" ["categories"]=> array(2) { [0]=> string(12) "Board Change" [1]=> string(10) "Executives" } } [1]=> array(7) { ["title_en"]=> string(102) "Royalty Pharma Appoints Henry A. Fernandez and Ted W. Love, M.D. to the Company’s Board of Directors" ["snippet_en"]=> string(158) "NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Royalty Pharma (Nasdaq: RPRX) today announced the appointments of Henry A. Fernandez and Ted W. Love, M.D. to..." ["url"]=> string(164) "https://globenewswire.com/news-release/2020/08/03/2071980/0/en/Royalty-Pharma-Appoints-Henry-A-Fernandez-and-Ted-W-Love-M-D-to-the-Company-s-Board-of-Directors.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/10f64c85-ef35-48c0-b585-602e2b59f993" ["source"]=> string(17) "globenewswire.com" ["publication_date"]=> string(10) "2020-08-03" ["categories"]=> array(2) { [0]=> string(12) "Board Change" [1]=> string(10) "Executives" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(18) } [1]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(11) } [2]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(9) } [3]=> array(2) { ["name"]=> string(13) "GHG Emissions" ["count"]=> int(4) } [4]=> array(2) { ["name"]=> string(24) "Systemic Risk Management" ["count"]=> int(3) } [5]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(2) } [6]=> array(2) { ["name"]=> string(34) "Physical Impacts of Climate Change" ["count"]=> int(2) } [7]=> array(2) { ["name"]=> string(5) "Fraud" ["count"]=> int(2) } [8]=> array(2) { ["name"]=> string(7) "Funding" ["count"]=> int(2) } [9]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(2) } [10]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(2) } [11]=> array(2) { ["name"]=> string(19) "Green & Responsible" ["count"]=> int(2) } [12]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(1) } [13]=> array(2) { ["name"]=> string(14) "Product Review" ["count"]=> int(1) } [14]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(1) } [15]=> array(2) { ["name"]=> string(11) "Slush Funds" ["count"]=> int(1) } [16]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(1) } [17]=> array(2) { ["name"]=> string(22) "Sustainable Investment" ["count"]=> int(1) } [18]=> array(2) { ["name"]=> string(10) "Tax Havens" ["count"]=> int(1) } [19]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(1) } [20]=> array(2) { ["name"]=> string(3) "War" ["count"]=> int(1) } [21]=> array(2) { ["name"]=> string(8) "Activism" ["count"]=> int(1) } [22]=> array(2) { ["name"]=> string(15) "Blogs & Columns" ["count"]=> int(1) } [23]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(1) } [24]=> array(2) { ["name"]=> string(17) "Commodity Pricing" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(9) "Investors" ["count"]=> int(1) } } } 8b2a4-us-msci-inc